MDGL
Madrigal Pharmaceuticals Inc
516.60$
+0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 100.0% | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | 100.0% | – | – | – | – | – | – | 100.0% | 100.0% | |
| – | – | – | 1,809.2% | – | – | – | – | 2.6% | – | 19.3% | 502.0% | – | – | – | – | 22.0% | – | – | – | – | – | – | 3.5% | 5.9% | |
| – | – | 100.0% | -1,709.2% | – | – | 100.0% | 100.0% | 97.4% | 100.0% | 80.7% | -502.0% | – | – | – | – | 100.0% | – | – | – | – | – | – | 96.5% | 94.1% | |
| – | – | 1,866.3% | 22,043.9% | – | – | 7,002.0% | 3,119.7% | 35.4% | 271.9% | 546.7% | 33,613.6% | – | – | – | – | 6,968.6% | – | – | – | – | – | – | 131.4% | 40.5% | |
| – | – | – | – | – | – | 2,010.0% | 563.7% | 8.8% | 77.3% | 152.3% | 7,942.9% | – | – | – | – | 2,192.0% | – | – | – | – | – | – | 241.5% | 84.9% | |
| – | – | 2,269.8% | 25,417.3% | – | – | 8,561.0% | 3,675.2% | 42.5% | 336.2% | 679.7% | 41,054.4% | – | – | – | – | 9,160.6% | – | – | – | – | – | – | 372.9% | 125.5% | |
| – | – | -2,169.8% | -26,211.6% | – | – | -8,912.0% | -3,583.5% | 55.8% | -249.3% | -599.1% | -41,556.5% | – | – | – | – | -9,160.6% | – | – | – | – | – | – | -276.4% | -31.3% | |
| – | – | 0.0% | 0.0% | – | – | 0.0% | 18.7% | 0.2% | 3.8% | 25.7% | 1,257.8% | – | – | – | – | 159.4% | – | – | – | – | – | – | 8.1% | 2.3% | |
| – | – | -2,137.9% | -26,551.4% | – | – | -8,545.8% | -3,541.8% | 54.8% | -253.1% | -624.7% | -42,714.3% | – | – | – | – | -8,901.1% | – | – | – | – | – | – | -258.6% | -30.1% | |
| – | – | -31.9% | 339.9% | – | – | -366.2% | – | 1.0% | – | 0.0% | 0.0% | – | – | – | – | -181.4% | – | – | – | – | – | – | -258.6% | – | |
| – | – | -2,137.9% | -26,551.4% | – | – | -8,545.8% | -3,541.8% | 54.8% | -253.1% | -624.7% | -42,714.3% | – | – | – | – | -8,901.1% | – | – | – | – | – | – | -258.6% | -30.1% | |
| – | – | -2,092.6% | -25,657.2% | – | – | -8,094.8% | -3,419.2% | 56.8% | -236.2% | -579.7% | -40,954.4% | – | – | – | – | -9,138.6% | – | – | – | – | – | – | -249.9% | -27.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.